Trademark: 79391412
Word
BGLAIVE
Status Date
Thursday, March 14, 2024
Filing Date
Wednesday, December 6, 2023
5 Anti-CD20 recombinant monoclonal antibody for medical use
Mar 14, 2024
Sn Assigned For Sect 66a Appl From Ib
Mar 19, 2024
Limitation From Original Application Entered
Mar 21, 2024
New Application Office Supplied Data Entered
Apr 24, 2024
Application Filing Receipt Mailed
Trademark Alertz updated from USPTO on 2030-01-24